The changes are intended to improve the efficiency of the OPTN Kidney Paired Donation Pilot Program (KPDPP), improve clarity around the living donation process and update informed consent for participants in all KPD programs.
Programs must complete the process and provide the necessary documentation to the OPTN by Jan. 3, 2024.
Previous use of race-based calculations disadvantaged some Black patients by overestimating their kidney function.
The goal is to help decision makers make evidence-based decisions to benefit candidates when determining whether to accept or refuse an offer.
The new formula for Calculated Panel Reactive Antibody (CPRA) will now go into effect on Jan. 26, 2023.
Report evaluates and compares several potential scenarios, will inform committees in their work.